Respiratory failure
The term respiratory failure, in medicine, is used to describe inadequate gas exchange by the respiratory system, with the result that arterial oxygen and/or carbon dioxide levels cannot be maintained within their normal ranges. A drop in blood oxygenation is known as hypoxemia; a rise in arterial carbon dioxide levels is called hypercapnia. The normal reference values are: oxygen PaO2 greater than 60 mmHg (8.0 kPa), and carbon dioxide PaCO2 less than 45 mmHg (6.0 kPa). Classification into type I or type II relates to the absence or presence of hypercapnia respectively.
Types
Type 1
Type 1 respiratory failure is defined as hypoxaemia without hypercapnia, and indeed the PaCO2 may be normal or low. It is typically caused by a ventilation/perfusion (V/Q) mismatch; the volume of air flowing in and out of the lungs is not matched with the flow of blood to the lungs. The basic defect in type 1 respiratory failure is failure of oxygenation characterized by:
-
-
-
PaO2 |
low (< 60 mmHg (8.0 kPa)) |
PaCO2 |
normal or low |
PA-aO2 |
increased |
This type of respiratory failure is caused by conditions that affect oxygenation such as:
Type 2
The basic defect in type 2 respiratory failure is characterized by:
-
-
-
PaO2 |
decreased |
PaCO2 |
increased |
PA-aO2 |
normal |
pH |
decreased |
Type 2 respiratory failure is caused by increased airway resistance; both oxygen and carbon dioxide are affected. Defined as the build up of carbon dioxide levels (PaCO2) that has been generated by the body. The underlying causes include:
- Reduced breathing effort (in the fatigued patient)
- A decrease in the area of the lung available for gas exchange (such as in emphysema).
Causes
Chest X-ray showing ARDS
- Pulmonary dysfunction
- Cardiac dysfunction
- Other
- Fatigue due to prolonged tachypnoea in metabolic acidosis
- Intoxication with drugs (e.g., morphine, benzodiazepines) that suppress respiration.
- Neurological Disease
- Toxic Epidermal Necrolysis
Treatment
Mechanical Ventilator
Emergency treatment follows the principles of cardiopulmonary resuscitation. Treatment of the underlying cause is required. Endotracheal intubation and mechanical ventilation may be required. Respiratory stimulants such as doxapram may be used, and if the respiratory failure resulted from an overdose of sedative drugs such as opioids or benzodiazepines, then the appropriate antidote such as naloxone or flumazenil will be given.
See also
- Ventilation/perfusion ratio
- Pulmonary shunt
References
Pathology of respiratory system (J, 460–519), respiratory diseases |
|
Upper RT
(including URTIs,
Common cold) |
|
sinuses: Sinusitis
nose: Rhinitis (Vasomotor rhinitis, Atrophic rhinitis, Hay fever) · Nasal polyp · Rhinorrhea · nasal septum (Nasal septum deviation, Nasal septum perforation, Nasal septal hematoma)
tonsil: Tonsillitis · Adenoid hypertrophy · Peritonsillar abscess
|
|
|
pharynx: Laryngopharyngeal reflux (LPR) · Pharyngitis (Strep throat) · Retropharyngeal abscess
larynx: Croup · Laryngitis · Laryngopharyngeal reflux (LPR) · Laryngospasm
vocal folds: Laryngopharyngeal reflux (LPR) · Vocal fold nodule · Vocal cord paresis
epiglottis: Epiglottitis
trachea: Tracheitis · Tracheal stenosis
|
|
|
Lower RT/lung disease
(including LRTIs) |
|
acute: Acute bronchitis
chronic: COPD (Chronic bronchitis, Acute exacerbations of chronic bronchitis, Acute exacerbation of COPD, Emphysema, Diffuse panbronchiolitis) · Asthma (Status asthmaticus, Aspirin-induced) · Bronchiectasis
unspecified: Bronchitis · Bronchiolitis (Bronchiolitis obliterans)
|
|
Interstitial/
restrictive
(fibrosis)
|
External agents/
occupational
lung disease
|
Pneumoconiosis ( Asbestosis, Baritosis, Bauxite fibrosis, Berylliosis, Caplan's syndrome, Chalicosis, Coalworker's pneumoconiosis, Siderosis, Silicosis, Talcosis, Byssinosis)
Hypersensitivity pneumonitis (Bagassosis, Bird fancier's lung, Farmer's lung)
|
|
Other
|
ARDS · Pulmonary edema · Löffler's syndrome/Eosinophilic pneumonia · Respiratory hypersensitivity (Allergic bronchopulmonary aspergillosis)
Hamman-Rich syndrome · Idiopathic pulmonary fibrosis · Sarcoidosis
|
|
|
Obstructive or
restrictive
|
|
By pathogen
|
Viral · Bacterial (Pneumococcal, Klebsiella) / Atypical bacterial (Mycoplasma, Legionnaires' disease, Chlamydiae) · Fungal ( Pneumocystis) · Parasitic · noninfectious (Chemical/Mendelson's syndrome, Aspiration/Lipid)
|
|
By vector/route
|
Community-acquired · Healthcare-associated · Hospital-acquired
|
|
By distribution
|
Broncho- · Lobar
|
|
IIP
|
UIP · DIP · BOOP-COP · NSIP · RB
|
|
|
Other
|
|
|
|
|
Pleural cavity/
mediastinum |
Pleural disease
|
|
|
Mediastinal disease
|
Mediastinitis · Mediastinal emphysema
|
|
|
Other/general |
Respiratory failure · Influenza · SARS · Idiopathic pulmonary haemosiderosis · Pulmonary alveolar proteinosis
|
|
|
anat(n, x, l, c)/phys/devp
|
noco(c)/cong/tumr, sysi/, injr
|
|
|
|
|
Organ failure |
|
General |
|
|
Multiple |
Multiple organ dysfunction syndrome
|
|